Phorm Corporation - Commercial Launch in China


SINGAPORE--(Marketwired - Jan 27, 2014) -


27 January 2014

                      Phorm Corporation Limited
                      ("Phorm" or the "Company")

         Commercial Launch in China and Global Operations Update

Phorm (AIM: PHRM), a leading internet personalisation technology
company, is pleased to announce that it is now serving advertisements
in the People's Republic of China and continues to make excellent
progress with its other global operations.

Highlights:

- Launch of commercial operations in China serving paid
  advertisements
- Operational launch achieved with 5 further ISPs since TTNET in
  Turkey
- Daily global user numbers are now in excess of 20 million
- Inventory deals provide access to over 80 billion page
  impressions per month
- Market leading conversion rates
- Gross revenue for Q4 2013 up 125% on the previous quarter

Phorm announced on 3 October 2013 that it had launched operationally in
China and had commenced a nation-wide opt-in process. The Company is
now pleased to announce that it has commenced commercial operations in
China and is serving advertisements on a paid basis.

Since launching with TTNET, a subsidiary of Turk Telecom Group, in
Turkey in 2012, Phorm has now successfully launched its platform with 5
further ISPs. Accordingly, on a global basis, there are now over 20
million daily users on Phorm's platform.

The Company is also pleased to announce that it has now achieved access
to over 80 billion monthly advertising impressions, on a global basis,
from its publisher partners.

In terms of revenue generation, campaigns in Turkey are increasing in
both size and volume. Gross consolidated revenue in Q4 2013 increased
125% quarter on quarter. Phorm has worked with all of the top 10
advertising agencies in Turkey running campaigns for over 300 local and
global brands driven by market leading conversion rates.

The Company currently anticipates revenue to increase significantly as
the growth in global user numbers accelerates with the expected launch
of operations with new ISPs and in new potential markets.

As previously announced, the Company intends to provide the market with
further updates on its key performance indicators (user numbers and
revenue) on a quarterly basis which will be reported on a consolidated
group basis in line with its current global activities.

                              -Ends-

For further information please contact:

Phorm Corporation Limited
Andy Croxson (analysts and investors) +44 (0) 203 397 6001

UK Investors
Mirabaud Securities LLP +44 20 7321 2508 (Broker)
Jason Woollard
Peter Krens

Strand Hanson Limited +44 20 7409 3494 (Nominated Adviser)
James Harris
Matthew Chandler
James Dance

US Investors
Lippert/Heilshorn and Associates +1 212 838 3777 (Investor Relations)
John Heilshorn

About Phorm

Phorm is a global personalisation technology company that makes content
and advertising more relevant to the consumer. Phorm's innovative
platform preserves user privacy and delivers a more interesting online
experience.

Phorm's industry leading technology enables its ISP partners to offer a
new type of online advertising platform and a free consumer internet
content feature, ensuring more relevant advertisements and personalised
content for opted-in users.

Phorm's advertising platform revolutionises current standards of online
privacy, fully protecting the identity of consumers. Unlike virtually
all other targeted advertising propositions, Phorm's solution is
completely opt-in. Only those users consenting to the service are
profiled and only ever on an anonymous basis.

Phorm's partners include leading Internet Service Providers (ISPs),
Publishers, Advertising Networks and Advertisers.

Phorm, under a predecessor holding company, was admitted to the AIM
market of the London Stock Exchange in 2004.

For more information, please visit:  www.phorm.com 




                    This information is provided by RNS
          The company news service from the London Stock Exchange

END

Contact Information:

Contacts:
RNS
Customer
Services
0044-207797-4400

http://www.rns.com